Entrectinib: observed
6 studies: patients on it are followed, or it is given outside a trial. Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Study on the Mechanism of Acquired Resistance of EntrectinibRecruitingNCT07199959Report a problem
- Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLCNot yet recruitingNCT06694129Report a problem
- A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.CompletedNCT05834348Results postedReport a problem
- Preoperative ROS1-TKI Therapy for ROS1 Fusion-Positive Locally Advanced Lung AdenocarcinomaCompletedNCT07700836Report a problem
- KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors IIActive, not recruitingNCT05525858Report a problem
- Expanded Access to Entrectinib for Cancers With NTRK1/2/3, ROS1, or ALK Gene FusionsNo longer availableNCT03066661Report a problem